Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Enjaymo Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Manufacturer
Generic Availability
Enjaymo Indications
Indications
Treatment of hemolysis in adults with cold agglutinin disease (CAD).
Enjaymo Dosage and Administration
Adult
See full labeling. Give by IV infusion over 1–2hrs based on body weight; infuse over 2hrs for patients with cardiopulmonary disease. Administer 6500mg (for patients weighing 39–<75kg) or 7500mg (for patients weighing ≥75kg) once weekly for the 1st 2 weeks, then every 2 weeks thereafter. Monitor for at least 2hrs after initial infusion and for 1hr after subsequent infusions for any infusion and/or hypersensitivity reactions.
Children
Enjaymo Contraindications
Not Applicable
Enjaymo Boxed Warnings
Not Applicable
Enjaymo Warnings/Precautions
Warnings/Precautions
Increased risk of serious infections (including encapsulated bacteria N. meningitides (any serogroup), S. pneumoniae, H. influenzae). Vaccinate or revaccinate against encapsulated bacteria at least 2 weeks prior to initiation according to current ACIP guidelines; if urgent treatment is indicated in an unvaccinated patient, give vaccine(s) as soon as possible. Active systemic infections: monitor closely for worsening infection. Consider interruption if undergoing treatment for serious infections. Chronic systemic infections (eg, HBV, HCV, or HIV): not studied. Discontinue and provide supportive measures if hypersensitivity reactions occur. Monitor for infusion-related reactions, recurrent hemolysis after treatment discontinuation. Potential risk for autoimmune diseases (eg, SLE); monitor. Pregnancy. Nursing mothers.
Enjaymo Pharmacokinetics
Elimination
Enjaymo Interactions
Enjaymo Adverse Reactions
Adverse Reactions
Rhinitis, headache, hypertension, acrocyanosis, Raynaud’s phenomenon, UTI, respiratory tract infection, bacterial infection, dizziness, fatigue, peripheral edema, arthralgia, cough, hypertension, nausea.
Enjaymo Clinical Trials
See Literature
Enjaymo Note
Not Applicable
Enjaymo Patient Counseling
See Literature
Images
